Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-03-05, Stock:LLY, The news for the past five days is as follows:
2021-02-26: NEWS1: Eli Lilly (LLY) Gains As Market Dips: What You Should Know.NEWS2: Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning.NEWS3: U.S. Government to Purchase Minimum of 100,000 Doses of Etesevimab and Bamlanivimab Neutralizing Antibody Therapy.NEWS4: Global COVID cases top 113 million as FDA committee meets to vote on J&J vaccine.NEWS5: Eli Lilly Signs $210 Million Deal With U.S. for Covid-19 Antibody Therapy.NEWS6: US Government Calls For Additional Eli Lilly COVID-19 Antibody Therapy.NEWS7: What's Moving The Market Friday? US Stocks Near Flat, Euro, Asian Stocks Lower.NEWS8: UPDATE 2-U.S. to buy at least 100,000 doses of Lilly's COVID-19 antibody therapy.NEWS9: Eli Lilly says U.S. government has agreed to buy at least 100,000 doses of its COVID antibody therapy.NEWS10: Lilly announces additional doses of neutralizing antibody therapy purchased by U.S. government to treat COVID-19.
2021-03-01: nan
2021-03-02: nan
2021-03-03: NEWS1: Vir Stock Craters On Weak Results For Glaxo-Partnered Covid Treatment.NEWS2: Vir Shares Plummeted Today. What to Know..NEWS3: Vir Biotechnology Shares Are Trading Lower As COVID-19 Study VIR-7831 Arm To Stop Enrollment.NEWS4: Eli Lilly/Incyte's Baricitinib Shows Benefit In Patchy Hair Loss Disorder.NEWS5: Baricitinib is First JAK-Inhibitor to Demonstrate Hair Regrowth in Phase 3 Alopecia Areata (AA) Trial.
2021-03-04: NEWS1: Tirzepatide achieved superior A1C and body weight reductions across all three doses compared to injectable semaglutide in adults with type 2 diabetes.

Answer: Rise